logo

6550--Fy27 Qiagen Reagents And Controls

Sector: Government • Location: United States of America

Source: SAM.gov

Tender
Special Notice

The Department of Veterans Affairs, NCO 8, intends to award a sole source, firm fixed price contract under FAR 6.302 1, Only One Responsible Source, to QIAGEN LLC, Germantown, MD, for QuantiFERON (QFT) TB Gold Plus II reagents and controls used for Interferon Gamma Release Assay (IGRA) testing at the James A. Haley Veterans Hospital (JAHVH). The contract will be established as a five year BPA (Bas

Status
Prospective
Sector
Government, Residential, Commercial, Hospital, Manufacturing (Industrial)
Location
United States of America
Updated
3 Nov 2026
Source
SAM.gov

ConstructChat

Ask ConstructChat about 6550--Fy27 Qiagen Reagents And Controls

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Tender Information FAQ

Tender Information

3 Q
The tender “6550--Fy27 Qiagen Reagents And Controls” is a tender record in Taiyo, linked to the Government sector. It is issued for works, goods, or services related to United States of America.

Participants

Not available for this record.

Status

Original status

special notice

Taiyo status

Prospective

Taiyo last update

2026-11-03

Contact

Not available for this record.

Description

Description

The Department of Veterans Affairs, NCO 8, intends to award a sole source, firm fixed price contract under FAR 6.302 1, Only One Responsible Source, to QIAGEN LLC, Germantown, MD, for QuantiFERON (QFT) TB Gold Plus II reagents and controls used for Interferon Gamma Release Assay (IGRA) testing at the James A. Haley Veterans Hospital (JAHVH). The contract will be established as a five year BPA (Base Year + 4 Option Years). The applicable NAICS code is 334516 (Analytical Laboratory Instrument Manufacturing), PSC 6640. This notice is not a solicitation. No solicitation will be issued. The Government intends to solicit and negotiate with only one source, as the required QuantiFERON TB Gold Plus II reagents are exclusively manufactured by QIAGEN and are uniquely compatible with the DiaSorin LIAISON XL analyzer currently in use at JAHVH. Interested parties may submit capability statements demonstrating the ability to provide fully compatible supplies no later than 10:00 AM ET, August 28, 2026, to Quentin.Ford@va.gov. Proprietary information must be clearly marked. The Government will evaluate responses solely to determine whether competition is viable; however, a decision not to compete remains at the Government s discretion. Point of Contact: Quentin Ford, Contracting Officer, NCO 8 Statement of Need QIAGEN QuantiFERON TB Gold Plus II Reagents and Controls Overview: The Pathology and Laboratory Medicine Service at JAHVH requires FDA approved, DiaSorin compatible reagents and controls for QuantiFERON TB Gold Plus II testing to support in house IGRA testing for Veterans and employee TB screening. Requirement Summary: Provide QIAGEN QuantiFERON TB Gold Plus II reagents and controls fully compatible with the DiaSorin LIAISON XL analyzer. Support continuous IGRA testing for clinical and occupational health needs. Furnish monthly deliveries of required reagents; shipping included. Supply products meeting CAP, JCAHO, and VA laboratory standards. No site preparation required equipment already installed. Routine daily maintenance and QC performed by VA staff. Equipment maintenance is covered under a separate DiaSorin service contract.

Original sector

Not Identified

Location

Country

United States of America (USA)

Source

Source

SAM.gov

URL

More Details

Record type

Tender

Sector

Government, Residential, Commercial, Hospital, Manufacturing (Industrial)

Article published date

2026-08-25

More on this tender

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this tender
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this tender